Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × sovateltide × Clear all

NCT01773785 2021-10-13

Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms